leuprorelin acetate
SpainDrugs containing this active substance
-
It is used to treat hormone-dependent metastatic prostate cancer in adult men and hormone-dependent high-risk non-metastatic prostate cancer when combined with radiotherapy.
Form: powder and solvent for solution for injection in pre-filled syringe
Active substance Dosage leuprorelin acetate 58,2 (JERINGA B mg Manufacturer: Recordati Industria Chimica E Farmaceutica S.P.A.
-
It is used to treat hormone-sensitive metastatic prostate cancer in adult men and hormone-sensitive high-risk non-metastatic prostate cancer in combination with radiotherapy.
Form: powder and solvent for solution for injection in pre-filled syringe
Active substance Dosage leuprorelin acetate 28,2-JERINGA B mg Manufacturer: Recordati Industria Chimica E Farmaceutica S.P.A.
-
It is used to treat advanced prostate cancer in men, prostate tumors in combination with radiotherapy, endometriosis and uterine fibroids (for 6 months), breast cancer in pre- and perimenopausal women, preservation of ovarian function during chemotherapy, and to treat central precocious puberty in children.
Form: powder and solvent for preparation of prolonged-release injectable suspension
Active substance Dosage leuprorelin acetate 3,75 mg Manufacturer: Gp Pharm S.A.
-
It is used for the treatment of advanced prostate cancer and also for localized or locally advanced prostate tumors when combined with radiotherapy.
Form: powder and solvent for preparation of prolonged-release injectable suspension
Active substance Dosage leuprorelin acetate 22,5 mg Manufacturer: Gp Pharm S.A.
-
It is used to reduce testosterone and estrogen levels in the body. It is indicated for the treatment of advanced prostate cancer and also for high-risk localized prostate cancer or locally advanced prostate cancer when combined with radiotherapy.
Form: powder and solvent for solution for injection in pre-filled syringe
Active substance Dosage leuprorelin acetate 28,58 mg Manufacturer: Abbvie Spain, S.L.U.